ArticleDrug design, development and therapy2026

Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in Patients with Platinum-Resistant or Immunotherapy-Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective, Real-World Study.

Kailin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.